IKIyoko Katoh

Iyoko Katoh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iyoko Katoh has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Shun-Ichi Kurata

    Redox Response Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

    4 shared publications
  • Nahoko Fukunishi

    C Medical Research Institute, Tokyo Medical and Dental University , Tokyo , Japan

    3 shared publications
  • Kohji Moriishi

    Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi 409-3898, Japan

    2 shared publications
  • Ryu-Ichiro Hata

    B Oral Health Science Research Center, Kanagawa Dental University , Yokosuka , Japan

    2 shared publications
  • Yoji Ikawa

    Institute of Physical and Chemical Research Ikawa Laboratory RIKEN Saitama Japan

    2 shared publications
  • Anna Mírová

    Department of Microbiology Interdisciplinary Graduate School of Medicine and Engineering University of Yamanashi Yamanashi Japan

    1 shared publication

Latest Publications

  • Open Access

    Repression of Wnt/β-catenin response elements by p63 (TP63)

    by Iyoko Katoh, Nahoko Fukunishi, Masahiro Fujimuro, Hirotake Kasai, Kohji Moriishi, Ryu-Ichiro Hata, Shun-Ichi Kurata

    Submitted: TP63 (p63), a member of the tumor suppressor TP53 (p53) gene family, is expressed in keratinocyte stem cells and well-differentiated squamous cell carcinomas to maintain cellular potential for growth and differentiation. Controversially, activation of the Wnt/beta-catenin signaling by p63 (Patturajan M. etal., 2002, Cancer Cells) and inhibition of the target gene expression (Drewelus I. etal., 2010, Cell Cycle) have been reported. Upon p63 RNA-silencing in squamous cell carcinoma (SCC) lines, a few Wnt target gene expression substantially increased, while several target genes moderately decreased. Although Delta Np63 alpha, the most abundant isoform of p63, appeared to interact with protein phosphatase PP2A, neither GSK-3 beta phosphorylation nor beta-catenin nuclear localization was altered by the loss of p63. As reported earlier, Delta Np63 alpha enhanced beta-catenin-dependent luc gene expression from pGL3-OT having 3 artificial Wnt response elements (WREs). However, this activation was detectable only in HEK293 cells examined so far, and involved a p53 family-related sequence 5 ' to the WREs. In Wnt3-expressing SAOS-2 cells, Delta Np63 alpha rather strongly inhibited transcription of pGL3-OT. Importantly, Delta Np63 alpha repressed WREs isolated from the regulatory regions of MMP7. Delta Np63 alpha-TCF4 association occurred in their soluble forms in the nucleus. Furthermore, p63 and TCF4 coexisted at a WRE of MMP7 on the chromatin, where beta-catenin recruitment was attenuated. The combined results indicate that Delta Np63 alpha serves as a repressor that regulates beta-catenin-mediated gene expression.


  • Open Access

    Impacts of Endogenous Retroviruses on Tumorigenesis, Immunity, Stem Cells, and Research Safety

    by Iyoko Katoh

    Impacts of Endogenous Retroviruses on Tumorigenesis, Immunity, Stem Cells, and Research Safety


  • Open Access

    Association of Endogenous Retroviruses and Long Terminal Repeats with Human Disorders

    by Iyoko Katoh, Shun-Ichi Kurata

    Since the human genome sequences became available in 2001, our knowledge about the human transposable elements which comprise ~40% of the total nucleotides has been expanding. Non- LTR (long terminal repeat) retrotransposons are actively transposing in the present-day human genome, and have been found to cause ~100 identified clinical cases of varied disorders. In contrast, almost all of the human endogenous retroviruses (HERVs) originating from ancient infectious retroviruses lost their infectivity and transposing activity at various times before the human-chimpanzee speciation (~6 million years ago), and no known HERV is presently infectious. Insertion of HERVs and mammalian apparent LTR retrotransposons (MaLRs) into the chromosomal DNA influenced a number of host genes in various modes during human evolution. Apart from the aspect of genome evolution, HERVs and solitary LTRs being suppressed in normal biological processes can potentially act as extra transcriptional apparatuses of cellular genes by re-activation in individuals. There has been a reasonable prediction that aberrant LTR activation could trigger malignant disorders and autoimmune responses if epigenetic changes including DNA hypomethylation occur in somatic cells. Evidence supporting this hypothesis has begun to emerge only recently: a MaLR family LTR activation in the pathogenesis of Hodgkin’s lymphoma and a HERV-E antigen expression in an anti-renal cell carcinoma immune response. This mini review addresses the impacts of the remnant-form LTR retrotransposons on human pathogenesis.


  • Open Access

    Activation of the Long Terminal Repeat of Human Endogenous Retrovirus K by Melanoma-Specific Transcription Factor MITF-M

    by Iyoko Katoh, Anna Mírová, Shun-Ichi Kurata, Yasushi Murakami, Kenji Horikawa, Natsuko Nakakuki, Takunobu Sakai, Kunihiko Hashimoto, Ayako Maruyama, Takaaki Yonaga, et al.


  • Open Access

    Induction of ΔNp63 by the Newly Identified Keratinocyte-Specific Transforming Growth Factor β Signaling Pathway with Smad2 and IκB Kinase α in Squamous Cell Carcinoma

    by Nahoko Fukunishi, Iyoko Katoh, Yoshiya Tomimori, Keiichi Tsukinoki, Ryu-Ichiro Hata, Atsuhito Nakao, Yoji Ikawa, Shun-Ichi Kurata


  • Production of the long and short forms of MFG-E8 by epidermal keratinocytes

    by Tatsuya Watanabe, Rakuno Totsuka, Seiji Miyatani, Shun-Ichi Kurata, Shingo Sato, Iyoko Katoh, Shizuko Kobayashi, Yoji Ikawa

    Mouse milk fat globule-EGF factor 8, MFG-E8, is the ortholog to the human mammary tumor marker, lactadherin, and comprises two spliced variants, the L and S forms. Recent studies have suggested that MFG-E8-L produced by macrophages and Langerhans cells in the skin serves as a linker between phagocytic cells and apoptotic cells, and that MFG-E8-S, also termed SED1, facilitates sperm-egg interaction for fertilization. However, Mfge8 gene expression occurs in various tissues apparently unrelated to these critical events. Our in situ hybridization study has revealed that Mfge8 is expressed in the periderm (the premature epidermis) on embryonic day-14, well before Langerhans cells begin to grow in the prenatal phase. Mfge8 transcript is detectable in the basal and spinous layers throughout skin development, whereas immunostaining has revealed MFG-E8 protein accumulation in the spinous layer. Cultured keratinocyte stem cells consistently express Mfge8-L and -S mRNAs and produce the L protein, which is primarily detectable in the culture supernatant, and the S protein, which is mostly associated with the cells. Upon Ca2+-stimulated differentiation, which is detected by a decrease in keratinocyte stem cell marker p63(p51) and the induction of keratin1, we have observed suppression of Mfge8, and the protein becomes localized to the cell-cell borders. Papillomas and carcinomas caused by chronic UV-B irradiation produce MFG-E8 as determined by immunostaining. Thus, undifferentiated and poorly differentiated keratinocytes produce the L and S forms of MFG-E8 during normal and pathological tissue development, probably to support an as yet unidentified membrane function.